Linagliptin Interactions
There are 348 drugs known to interact with linagliptin, along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 2 are major, 345 are moderate, and 1 is minor.
- View all 348 medications that may interact with linagliptin
- View linagliptin alcohol/food interactions (1)
- View linagliptin disease interactions (1)
Most frequently checked interactions
View interaction reports for linagliptin and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Celebrex (celecoxib)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Jardiance (empagliflozin)
- Lantus (insulin glargine)
- Lantus SoloStar (insulin glargine)
- Lasix (furosemide)
- Levothyrox (levothyroxine)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Nexium (esomeprazole)
- Ozempic (semaglutide)
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- Seroquel (quetiapine)
- Symbicort (budesonide / formoterol)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Linagliptin alcohol/food interactions
There is 1 alcohol/food interaction with linagliptin.
Linagliptin disease interactions
There is 1 disease interaction with linagliptin which include:
More about linagliptin
- linagliptin consumer information
- Compare alternatives
- Reviews (81)
- Side effects
- Dosage information
- During pregnancy
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.